<SEC-DOCUMENT>0001193125-14-158524.txt : 20140425
<SEC-HEADER>0001193125-14-158524.hdr.sgml : 20140425
<ACCEPTANCE-DATETIME>20140425100203
ACCESSION NUMBER:		0001193125-14-158524
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140424
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140425
DATE AS OF CHANGE:		20140425

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORTHOFIX INTERNATIONAL N V
		CENTRAL INDEX KEY:			0000884624
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19961
		FILM NUMBER:		14783335

	BUSINESS ADDRESS:	
		STREET 1:		7 ABRAHAM DE VEERSTRAAT
		STREET 2:		CURACAO
		CITY:			NETHERLANDS ANTILLES
		STATE:			P8
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d717773d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): April&nbsp;24, 2014 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix International N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Cura&ccedil;ao</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-19961</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7 Abraham de Veerstraat</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cura&ccedil;ao</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: 011-59-99-465-8525 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (<I>see</I> General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</U>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;24, 2014, the Board of Directors (the &#147;<U>Board</U>&#148;) of Orthofix International N.V. (the &#147;<U>Company</U>&#148;)
held a meeting at which the following actions were taken: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Appointment of James F. Hinrichs as a Director </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board appointed James F. Hinrichs as a director, effective immediately. The Board has determined that Mr.&nbsp;Hinrichs is an independent
director under the rules of the Nasdaq Stock Market. There are no transactions involving Mr.&nbsp;Hinrichs requiring disclosure under Item&nbsp;404(a) of Regulation S-K. In connection with Mr.&nbsp;Hinrichs&#146; appointment, the Board adopted a
resolution increasing its size from nine to ten directors, effective immediately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As further described below, effective as of the
Company&#146;s 2014 Annual General Meeting of Shareholders (the &#147;<U>2014 AGM</U>&#148;), the Board has appointed Mr.&nbsp;Hinrichs as Chair of the Board&#146;s Audit and Finance Committee, and as a member of its Nominating and Governance
Committee. Mr.&nbsp;Hinrichs will receive the Company&#146;s standard fee of $60,000 per year for non-employee director service plus $15,000 per year for service as Chair of the Audit and Finance Committee. In connection with his appointment, he has
been granted options to acquire 30,000 shares of common stock pursuant to the Company&#146;s 2012 Long-Term Incentive Plan (vesting in 1/4th increments on each of the first, second, third and fourth anniversary of his appointment pursuant to the
Company&#146;s previously filed form of non-employee director non-qualified stock option agreement). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Retirement of Walter P. von Wartburg and Kenneth
R. Weisshaar </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Walter P. von Wartburg and Kenneth R. Weisshaar, who are currently serving directors, each notified the Board of his
respective intention to retire from the Board as of the 2014 AGM. The Board accepted Dr.&nbsp;von Wartburg and Mr.&nbsp;Weisshaar&#146;s respective retirements from the Board effective as of the 2014 AGM, and expresses its gratitude to each of them
for their many years of service to the Company as directors. Dr.&nbsp;von Wartburg and Mr.&nbsp;Weisshaar&#146;s retirements are not related to any disagreement with the Company or the Board regarding any matter related to the Company&#146;s
operations, policies or practices. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>2014 AGM Matters; Board Committee Composition </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board resolved that the size of the Board shall be reduced from ten to eight directors effective as of the 2014 AGM, and that the following
persons shall be nominated by the Board for election at the 2014 AGM to one-year terms as directors: Mr.&nbsp;Hinrichs, Guy J. Jordan, PhD, Anthony F. Martin, PhD, Bradley R. Mason, Ronald A. Matricaria (Chairman), Kathleen T. Regan, Maria Sainz and
Davey S. Scoon. The Board has determined that each of these nominees, other than Mr.&nbsp;Mason (who is the Company&#146;s President and Chief Executive Officer), is an independent director under the rules of the Nasdaq Stock Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board further resolved that the composition of the committees of the Board shall be reconstituted as follows effective as of the 2014 AGM:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Audit and Finance Committee:</I> Messrs. Hinrichs and Scoon and Ms.&nbsp;Regan, with Mr.&nbsp;Hinrichs serving as Chair; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Compensation Committee:</I> Dr.&nbsp;Jordan, Mr.&nbsp;Scoon and Ms.&nbsp;Sainz, with Dr.&nbsp;Jordan serving as Chair; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Compliance Committee:</I> Ms.&nbsp;Sainz and Drs. Jordan and Martin, with Ms.&nbsp;Sainz serving as Chair; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Nominating and Governance Committee:</I> Ms.&nbsp;Regan, Dr.&nbsp;Martin and Mr.&nbsp;Hinrichs, with Ms.&nbsp;Regan serving as Chair. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>Regulation FD Disclosure</U>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;25, 2014, the Company issued a press
release regarding certain of the matters described in Item&nbsp;5.02. That press release is furnished herewith as Exhibit 99.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
information included in this Current Report on Form 8-K under this Item&nbsp;7.01 (including Exhibit&nbsp;99.1) shall not be deemed &#147;filed&#148; for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the
&#147;<U>Exchange Act</U>&#148;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended, except
as shall be expressly set forth by specific reference in such a filing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>Financial Statements and Exhibits</U>. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>(d)</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top">Exhibits</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top">Press Release, dated April&nbsp;25, 2014.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Orthofix International N.V.</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jeffrey M. Schumm</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey M. Schumm</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Administrative
Officer, General</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Counsel and Corporate Secretary</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: April&nbsp;25, 2014 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:23.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit<BR>No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated April 25, 2014.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d717773dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g717773g83z34.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix, International N.V.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3451 Plano
Parkway</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lewisville, TX 75056 USA</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel 214 937 2000</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Orthofix.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>News Release </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONTACT:
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Quick </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel 214 937 2924 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">markquick@orthofix.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix Appoints James F. Hinrichs to its Board of Directors </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Mr.&nbsp;Hinrichs to Become Chair of Audit and Finance Committee</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LEWISVILLE, TX. &#150; April&nbsp;25, 2014 &#150; Orthofix International N.V. (NASDAQ:OFIX) announced today that it has appointed James F. Hinrichs to its
Board of Directors, effective immediately. Mr.&nbsp;Hinrichs joins the Board with more than twenty years&#146; experience at leading healthcare companies. Effective as of the Company&#146;s 2014 Annual General Meeting of Shareholders scheduled for
June&nbsp;19, 2014, Mr.&nbsp;Hinrichs will become the Chair of the Board&#146;s Audit and Finance Committee and a member of its Nominating and Governance Committee. The Board has determined that Mr.&nbsp;Hinrichs is independent under applicable
rules of the Nasdaq Stock Market, and qualifies as an &#147;audit committee financial expert&#148; under applicable rules of the Securities and Exchange Commission. With his appointment, the Board now includes five members who have been appointed
since March 2013, four of whom are independent, outside directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Jim&#146;s experience as a public company CFO, combined with his knowledge of
the medical device industry and related financial environment, make him an ideal director for our Board and future Chair of our Audit and Finance Committee,&#148; said Orthofix Chairman Ron Matricaria. &#147;We believe he will bring added depth to
these roles as we work to improve our reporting processes and realize our full potential.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>James Hinrichs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Hinrichs has served as the Chief Financial Officer of CareFusion Corporation since 2010, where he also has responsibility for corporate development
and investor relations activities. He previously served as CareFusion&#146;s Senior Vice President, Global Customer Support, and as its Senior Vice President, Controller. Prior to joining CareFusion when it was spun off from Cardinal Health, Inc.,
he worked for five years at Cardinal Health in various positions including Executive Vice President and Corporate Controller of Cardinal Health and as Executive Vice President and Chief Financial Officer of its Healthcare Supply Chain Services
segment. He joined Cardinal Health following more than a decade of finance and marketing roles at Merck&nbsp;&amp; Co. He holds undergraduate and graduate degrees in business from Carnegie Mellon University. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Orthofix </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. is a
diversified, global medical device company focused on improving patients&#146; lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. Headquartered in Lewisville, TX, the company has four
strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Orthofix products are widely distributed via the company&#146;s sales representatives, distributors and subsidiaries. In addition, Orthofix is
collaborating on research and development activities with leading clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation and the Texas Scottish Rite Hospital for Children. For more
information, please visit www.orthofix.com. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g717773g83z34.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g717773g83z34.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`*P$.`P$1``(1`0,1`?_$`+X```$%`0$``P$`````
M```````'"`D*"P$&`@,%!`$!``("`P$!``````````````<)!@@!`P0"!1``
M``8!`P($`P0$"08/`````0(#!`4&!P`1"!()(1,4"C$B%4%1%A=A<3(8\(&1
MH;$C)34YP4)28B=W<C-#4R0TM3:V-[<H>+@9$0`!`P(%`@,$"`(+```````!
M``(#$00A,1(%!A,'05%A<2(R%(&AP4)2(Q4(D6/PX?%R@C-3@T0U%O_:``P#
M`0`"$0,1`#\`OG7&Y5VC0;N?LTBG'1C4ANM3R';UTNIT[IM(Z,C6[R4E9!<?
M!-NV1574'P*41\-=D,,ER_HP#4\^H`'J7'!H\W$@#,X+SW5S#:0.GN#IC`)R
M))PR#1BXGP:*EQP&*K=]QOO%<H<:0TO#<;N*6:,85H?.:J\D<[8?MD(R*7Y4
M_64VHS$4$:P`/$47<ZH!O@/HB^`ZV/[:=EN*;R8[OEF[V$TKR"VSMKB(R>G6
M(<2[#&C`37'5@M7NYO>[F&T,DM>)[1N%O:@D&[N;>4-(R_):6@-&=2_P\`JC
MF2,L9,S+:']XRI?[5D.V2KE5Z^GK1,.I5XLLN8#F%`%3BW8H?*'2DW(DD0H`
M!2@``&MU=FV#9>+0,VK9;.**V8W52H!(P%?4G#'Q6D&][[O/)+F2_P!UE?<7
M,CR2XC!KLZ^T#"GDGC<2NYMR[X=SL6MCS)DO8Z$W=HGE\2WYZ[LU$F61>@%F
M;9N\54D:PY41)TINHU5N=(=A$JA=R#@O+NS?">8MGFW.'Y*_EJ]MQ"*OUY4<
M!\0.%21AYA9_PKN_S;A4D+-NOC=6K'`.M912(M\3J-*$9"A_BKVG!7F]BCG;
MA*/RUC@RD/)LG)83(="DW2"\]0+:1L1=>(?F1Z2O8YXF(K1[XI2IO&WS`!5"
MJ)DT`YQPC>NW^]NVG>VBI`,4@^"6,_"6NR+L@]N;78%6']ON>[1W`V1FZ;3I
M;*#IFB!!='*,P0,=+J$L-!J&(3UBB`@`AX@(!K$/;@LZJ#B,0@1`/$1``^\1
MVT1=T1<$0#XB`?K';1%W1$:(C?1$;[?TZ(N`8H^`"`C]P"'\/MT1=T1&B+@B
M!0W$0`/O$=@_E'1$`8!\0$!#[P$!T1`"`_`0'[/#QT1=W^S[=$7`$!^`@/B(
M>`[^(?$/#[0T1`B`?$0#]8AHB[HBX(@'Q$`_6.VB+NB(WV^.B(W_`)OC^C1%
MP1`/$1``_3X:(@#`/@`@(_'P$!^/PT1<ZB[[=1=_#PW#?Q^'A^G1%W<-]MPW
M^[?Q_DT1`B`?$0#?X;B`?TZ(NZ(OCUE_TB_=\0^_;[_OT11[\S>Y3Q0X31JG
MYK7M"7R&+074'B*E>FL.1)(YBB9$Z\8FNFUJ[%?P`7<FLU2$@B)/,$.D<UX9
MVXY;SNY^4V.W>RR!&JX?[D8'B278FGDT%Q\`HWYMW,XCP:W^8WB=DM^?@MV'
M6\N\*::AIKA5Q%,TQ/MB=SS(G<CY$\@ZE<:33Z5ANIXPAY.GXU*B2QR[L92T
M*Q,E)7.P2"1$)M5Q&G(D9J@U19(@IMTJ&$#C(O=+M)%VOX[MVX-NY)M]GNGQ
MRO95C8]+-;0W(GSKCY*/.U7=NX[K<DW*PEM8H]A@MFOCC>`\NJ\,<75KZX>:
M8'WJ>T'5,<56P<O^*M51KE<AES26;L2P+<I82)C%SE*OD>D1R0?V2P9KJ;R\
M:B`-TDC"Z1(F4BQ1D7L=WJW.XN(>%\KE;*U[@()G@EY=4`1.?Y4J6D^(H36E
M8X[]]CMMMK&7F?$XG1%AU7$3"`P-H:R-;G\5`0*YURRJQ?T?9L.X?Q#]NMPI
M&&.9S":@4^C#P6EL>,+7'XC7ZE*QV;N6<IQ8YL8\;NY-5OC;.4A&X@R*P46,
M##:QO2MJ;9#HCNB#RM6I=`05$.HK1RX)OL<=0QWTX1;<MX)/=,;7>[`&6"E*
MN8,9<3@*`95J2!0*<>PW.G</YO#!-(6;1??D39D->\UBDH`22#1N61-<%H7F
M62;-C+NE4T$4$CJKKK'(DDBDD43JJJJ&$J:::9"B)C"(``!N.JY`0X5!J/-6
M9YXTT^BSQ.[3[N;.0Y<N^!.V8A4ZA0*9-R517Y+6*ML;O<<C3$6Z<Q<A)XSJ
M\Z@\JE=IRKY,2Q[MZSD7S](I7!2M0.4@\HO/8*X7^[TY>TN'S#(<P<N8%B+9
M'IS,!&99Y#/L/SK^,?D3<LW:F-<:5Z2?5@CM$P&31D6+!P4HAND4HZ(F^<K,
MM>ZF[-Z4'E3//(S*-WQ(K.-(K\Q7UGJ?)C$"TL]45*R@;:XML')V*I'EA3$C
M?UZ$9Z@_R(*BIL`$5DSL%>XLC>Z5-/N,_(>I5K%O+FMUEQ:(9S3Q?)8\SA68
M1%/\2/ZQ&2CE[)52YU\ARN7D4=R[1<,Q4<ME"D1611(F8=]KW1E[X=9YNO"[
M@=5Z3+Y/QBH2'S)G/(<:M982HW%1NV>.J1CVGE<LHV8FJX@X*22D9,Z[-!Z)
MVI&BAD3JZ(HPN..1/>%\\ZE'9QP]D/+T)C2X-22M5L]F;<<<&U6Q13@RIF\G
M4H*U5^ORLK".2DW0>H,U&JY!*9-4Y1WT1)_REYA^["[6C"`R]RKRED&-QI)V
M!A7$+18(CCEF7&3F>>(NGC*O3;FIPLR:$>2;6/7\DBYV1W`)G!(XF+X$4C>)
MN['W=N]WP98U_MX.(/"7/;C;FNKEY(.:#9:12*9D;!MRHMT0JEQ@T<MFF$(E
MTM>(,R$A$HN%CHJHIKI*>2L**)$W+,N-?>-8#Q)DO-^3>2,[$8\Q)1K-D6[R
MC++'&*7>1]5J$2ZFYUXUBXZ'<OY%=M',U#E11(9102])0$1#1%$QQ$[MGN$.
M<>?J/QDX[\X<DV?,&1?Q"-4@YA;#M6CGH5:LRUNF17G9VG,XICZ>"@W*I?-5
M+UF(!"[F,`"139!Q:]ZE]O(&3_1_MIXK?'</C_9H[AHB9MWWN\?W3>)'<YSO
M@'"G,/)&-,?T>LX+(SI<(PHCV,B9R9P1CB<N!VKN2J4@\6"1MDB]=&,*QRB=
M8>C8G24"+1%X:VZRY`X@\5;]<Y=S8;C>>-^#KC;9]Z5`CR=L]FQC5YJ?F79&
MJ+=J1S)RKU5=0$DTTP.<>DI0V`"*`[W57-/E-P:X48+R7Q-S-9L)7FS<FHJF
MV"PU=K`NW<K5W&,LA3"L,X3L,/,MBM32D2V7W3(13K2`.KI$P"1--]MYW:LV
M9,X0=PWE9W(.2UFR+3.,=HJ$N>W6UC`$=5>I!1YF4DHF$85R'A0DI.?EDD$&
MC82G6=/5$DDQZC@`D4'_`"H]TMW4.<^<&>&>W?6W.!*W>;0E4,3T?'%*B,E\
MB;ZN]=J(1?UNQ3<58&+&:?(;+';P;)H@P)U`=RN5,RXD3SJOVP?=\WVO)W*<
MY[6_'4M)LT9#\$6;F59HZP-CKI`L5BX8X^A+#3HUT3J`ITB/0(0WRF$-AV(F
M%Y=[H_N3NR_F2O4OF#D6S6^+FBFD*[&9YBZ?FC%>4H:+7;FDSU7*L`DWL:RK
M;U"97*36::R++S4Q71(!R]1%=[[./>5Q!W:^-]ARA#Q#7$V7L0*L(KD%BN2E
MTW[*G.GT>[?QMQK\VNFS4D\=V5O&.SM7"Z:2[55HNW7`3)%55(JDO<2]VMS+
MRSR"G,%]KNO5^E8[;7%7'U"R`ICYME+-.;)I233@X^8JM:FVLS7(&+LLA_=,
M<E%O919)5,ZBQ%#B@F1*91,)>]/RM#M[>KE^YX[2ET2O&\->[YQ=I,N@DJ`'
M33<U5I#.W\,L)3>*#E%!9,0V.4HAMHB]P/$7WH^P_P#NB1'P'P+F7CD`_P`0
M_A0-OY=$30^^_P!V3NS\'N9U$P!1>7V0<:.H#B'Q=DLE5ZNH4"7BW.8Y3'2(
M91GDI%W4GI7:LU;&KA8ZB)B-U!'J3(4@@`$4\JD#W9>;'8\X9<M.&7-+*]5Y
ML1^#U[O=JVB2@_1>3B*L[+_48MZ25J;AI"9+8LXXH0KA#TS)WL9FY*`JI.$"
M*#'LY>YWY/X4Y22.".Z[E&UW_$]^L1*9(9#O]:C(*[\9L@QSY:&,ZLT=#0$"
MY5HRKX!;6!JX0,\BCI`Z3V*DX15(K(O?T[]&/^V?@UCCO`UBK&0>9F<JB25Q
M6RC7+"P5S%E%G6QTVF<;7Z=5RQD&SI,PFK+`QC)R[DOJ#@9D@IYA%"CV",@=
M^#N9W1YR#S+S<SM$<+L323M1Z'T_'M>D.1E^@B>M;8?I,T%"*HSKAWJ2:-DF
MT##Z)!3TC<P.U14:D4OM6Y;\YPREE$KO*=I<Q'U>JDA8AI1FEIE6YS3,>E/-
MY;';1!T]Q8>&R8DRIZ,2\09N9QE/`"(N5B'?-R*IGE1_89+*&2'UL=/WEG=W
MNU+3[N5556E%I;ZX^*\]:LJ<ZQEDUBB00$WR@&P;!L&K;-GM+*UV.*SL*,L&
ML9I,;6C42`?"@TUS^E4[;I=7,V]S7FX:WWQ>^H>20VA-,\:^2E8[$?("+P;W
M`*9#3[\D=7LZ5B=PZ[<JF`K<D_++Q\]2"JF,)0(+RQP2;,HB.W6\#42?N&V"
M??\`M[/=6C=5Q978NB*5/2#>F^E*_""7G(:6G%3'^W#DD&P=Q;>TNGZ+:^MG
M6Y.`'4)UL)J<G.:&CQJ1@K[L_$1%JA)6N3<>TEX.=CWT--13](%F4G$RC55C
M(L'2)@$JK=VS<G3.40V$IM5UPWDT4T5Q8.TW`(?&_(`M(-?.OEAFK&[N"VO(
M);*\8'VS@62-.-0X8>GB#[%F5<S\`K<7>5.=,#""GTW'M^E6-945`?,<TR4!
M&>ISDXF`!.8]:E&P&'[3E-JU7@7)1R_ANW[\`0^2`->#2O4C]UY-*X%P)'C3
M-5-]PN,GA_,]PV$T(BG+FD5TEC_>92M#@#0X9Y)N<0_=Q,O$2K!4R#Z+EHN2
M8K)B)3HO6#]N[:*D$/$#IN$2F#;[0#61;C`VXL+B.6G2^3F'\6E8YM4KHMRM
MGQ5Z@NXC]>"T=>XU>;?7NUSS,R#4S.&ET9<+,T6"+6:%5]6PE5\13C@[IJ*?
M2LDY8"L=0AB[&(<@&\!#52-S&V*XDB;\+7N`^@D*XFR>Z6SAD?\`&Z)I/M+0
M2LH7L.8_HV4^[YP'IV2F$=+U);.4?-+1<NDBXC9&8IM>L%RJ;!VV7`R#E)Q:
MX!D'E'`Q%A^00$#;#TKTK:#`H%WV#;<1,.WVB([B/ZQ'1$QKN;8^HN3^W?S>
MI>2&C%U3I7BUF]W+#(%2%NR6@,?3MCAIHIEOD2>0$Y$MGK93P,DX0(<H@8H#
MHBR7^PS9K%4^\+V]9*L.'+5^^Y(T^L/5&HG`ZM=N"3^K6IHL4@@)VSFMR[HJ
MF^Y0)N(_#1$V#D[;I"9[AW(2\V&O?F3)/N8^5;-+5!^+YT2].#9IG)%Q5''H
MBJ2*J%C$!8B5$IENA;9,.K8-$5P(GNS.Y?5882I]IBKUFN5R*`A2#6>0$5#P
M4'#,^DJ>Y8%NQC8R*CVVWB":***?^:4O@11#\^N^CW`^^M7\=<&JU@#&U=B[
M=D>&G8#%F&8VPSU]R5>8-E*_AU@K/VZ><@#.+0>N%P;,T&GG*`!E#F`@%T17
M!?;$]G+-?;#PWF;)G*%./KV>N2ZU'(OC&*EF,Z&-*#1$9UU"QUCF(I=U#NKE
M-RMJ<K/$6:SA!F@@@GYQE15*0BF-[L_^&#W!/_AUR'_]+['HBS$_:[_XWG#?
M_@9U_P#KUE'1%KZZ(L@WW1&P][GE_OX!Y.$=Q^X/R'QMHBF&P5W@O<\TO!^&
M:=BGMPKV3%U3Q/CFM8VL9>'&<IPM@H,%3X:+I\X$U'71"/E@EZ\U;N/4H$(B
MOYG60I2F``(HS^]#W`>]+RRX[XXHO<DX@J<?,1067V=HIUK4X]9*Q']7R"A4
M;/%MH$)VZV*88ONNOR;Y?TJ1"JF\KKZNE,0T1(;QZLEC@?;Q=Q1A!.'2#"W\
M^.'5:MP-C*%*O6TZ;?;,F@[%,0#TJEEKD<(@;Y3'*4/B(:(I*_9:X\H5I[B>
M>KM8V3%]<\9<79B0QUZL$SKQ3JTW^FUFSSD:4X=2;U.!=&8BH7YBMY!4N^QQ
MW(M.(```V`-@T15>/=Y4.C67L^6VUV1A''M&-\Y88G,=23AND>193D_8U*A.
M-(UR)171)(U*<?"N0H@50J!1,`^640(J4/8'RU><6M.[RZJL@\9Q_P#^/7+.
MQR)6PJ`0LY6EZ6UJ\CU%,5-%['#9'@(*"('+YQ^D0W'<BCS[76<,]<;>:^)L
MY<8N.S#E'G+')+7-4'$\E2+KD-!Q(K527BG5G1J^/WL?9G3ZHQL@L^;K(J@5
MJLD58W@GHBM^![BKW%H;B'9U:AOXB(<3N9'C^D=KKXZ(I<.S)W8>['SAY3VG
M$O./@0CQ?Q)$X<L=WB+Z3"&?L;FD+M%V:H1,76?K>4;!+0#D'\5-/G`MTR`Z
M-Z7J*/04X"15#/=Y?XR-U_W`8(_[#EM$5_7L`_X-7;X_W"Q__B2Q:(JK_O'.
M$W!['3S''+ZIW:`Q;S/R]/)PMKPQ"1Y7)L_U./;BVD,OS#!@<H5&=IODHLG,
MPN0$)XJA&YNMV@*@D50/@Y5N/V>.9&`:1SFS5:<:<=YVV5>K9(R;L]L#^"J,
M2S)&UZMC)NW*JE3K;PS-I#C*="S>O1ZHN`0,DWZ`(MLC"&+\38:Q'CW%6#JK
M6:;B"B52(K^.ZW3TVY*VPJS9HF>,/&*M3J)/R/T5?4J/!.JJ]55,NHHHHH8Y
MB)42-6R2JRZ;=%-=R*8N5B)D(JX%(O0D*ZA0`ZQDB>!1,(B4/`-$6=YWC..+
MSCESUS`U1C3,J7EM^&9J"X31,DR7C+F<ZUACVQMN@3PEQ2?('(`[D(9,1_;#
M>R'L+RJVY/VXL#J!N+(212XU<3CH)&8P(58O?GC,_%^XM_&V(BRN]$D1I1H!
MH7`'(XU!R48T?(2$1(,)>)?.HR6B7S.4BI-BL9L^C9*/<I/&$@R<$V.@[9.T
M2*)G+XE.4!#4MRQPSQ/M[D!UM*PL>"*@L>"UP^D$A0_:3SVMRRZM7%ES$X/8
MX9AS/>!^@A7_`+M/]SBF\Y<5QE.N,K&P?)R@0C5GD&JN%D6BUU:L$D6Q<E5)
M(WE@_CI?H`\@W2`QXYX8Q3`"1D3FK;[L]KMT[?[[++:Q.?Q>64]"2GP!V/3<
M1A4"I!--5!3&M++>SW=;;NX.Q0PW<L;.3QQCK,J*R:`!U1EGA5HK2I.05:/W
M`<:P8]Q^WN68D%>8Q+B62E.@O2(2!(A_&%%3P`#*GCXY`PC_`*(AK:[]M[Y'
M]LH@\DM;>3M%?(.'VE:F_N:ACB[I3:``Y]I`XT\RVGV*.WAE@&P<GN46$L*U
M]DL\_%M]@SV%5(IC)Q5+A'1)VY3+L2@/E-(^NQ[@1,.P"H8A/VC!J3N?\AM.
M+\,OMZNW`11VTD8%:.=)*-,8`\:DBOD*J->WG'+KE?,-NV.Q:3</N!(32K0R
M/WG$^P`D+3!N5&K&1:#:L;6N-2DJ9=ZC/4>R0Q]P0D:O989W`2\8?P\$W44]
M42'X[`;55+72O;JF`$IQ(K7'VJVAH8&@1_`!0+(C[A7:BYX]DSEG%Y9IE>O4
MMBS&V3([)''#E72X)[,5A-"NSJ4Y3D;P[CV[EO3[M#^F20DHV2!%!V8BAFXK
MM5`,/TN59VXV>]AP`ZQ]",^6G%'+4!E)C&((6&:P5)5&V42R2B12D7E(N(N=
MBJ<]547YMU`9*KR0-]Q*#E0-M$4:G=[]U39>?>!K5P\X9X'NF)*+F1`M6R7>
MKS*1DUE.XU-TY2,\H51JE/-)1M;9V@$@;R#@7S]VZ9'.V331!0YQ(G$>US[$
MO(>K\B*AW&.76-Y[$-(QC&2K[CQCJ]QCF$OEZNUGA'D"3(4O57H(RM8J%5@I
M5PI'B_21<R,@LBLDGY"`J*$566G.T77=\JKYLJ51!SW(X-V@N41`IT5N3S59
M)4HCL(%,0P"&^B+;-=M&K]JY8OFS=XR>-UFCQF[13<M735PF9%PV<MUBG27;
MKI'$IR&`2F*(@("`Z(LL[W&79BM':]Y$Q'-/B4QGZUQ9R9?6UCK;JH*/FCKC
M%FPCT)]I5F\HR.5S!U>5DFYWU5=@8GI3I'8;@9!N9<BM]>WF[WU8[H^!DL5Y
MAF8F$YN82@&;?)4&91JP#+U29@W8,LT5!@44P.+M4Z:-B9H%Z8V34*H4I&SM
MN4I%)IW:CD)VO^X,<YBD(7ASR'$QS&`I2A^5]C\1,(@`!HBS$_:\G*7O>\-0
M,8I1.&=2D`1`!,;]WG*9NDH#\1Z2B.WW!HBU]]$605[H@Q3=[GF$!3%,)$L(
ME,`"`])OR%QJ;I-M\#;&`=ON'1%J?\`S`;@EPJ,`@8#<2>.`@8!W`0'#M-$!
M`0^("`Z(JR'O6CE+V[^-A3'`!/S!A0(43``G,7#^5#"!0$?F$"@(^'V;Z(HH
MO;><&:KW(.TGW8>(EEET*X[R/D_#SNE6Y=NH\2IN1JO59.R4.RN6J(@NO&M+
M%%))O4TQ!19@JNF00,8!T10@XT#N0^W/YZ0&5;GA:;IMRI+B=J<HTM45*/<)
MY[QK-K>BG(B"OL4F6)GZ[/(LT'C)VS7![&OD4%%42+(F1$BM[4KWL/!UY4F[
MJ_\`%+D]6;JFS(+ROU=[C&YUT7X(=1T8^U2-MJ+Y=F*_RE56C$3]/B)-_#1%
M6X[PO?%Y%=\>PX[XRX!X^W2G8/KMO)9ZMARJ#+9.RQE._>A<0L18[>E5XOTQ
MDX5G)NB1T2P052;*.E557+@WE"D13*<&>R[E/MP]D[NS\D^4D+^$N1W(C@YE
M^LQ..5'+9S)8HQ)&TN7G0B;4NS47:(W6Z3WIW+YDFJJ$>A'-DCF!P9=-,BA.
M]IL;;O78##?;JQGR%#X[;[8?M)MOT^!=_P"+1%K7:(C1%E"^[Q,`]Y&[``@(
MEP#@@#``@(E'Z#*&V$/L'I,`_J'1%9\P+W@,"=I7V\_`*^75S%W;.]VX\&C\
M"8&;RR;:=OM@;V.P-U9Z<!`5'D#C:KN%B*2LF8@;CTM6XF=+)ET15,N#?#GF
MS[D[N%7'+F=;O8W%';3,78.26=C,S)UW&]&*X44KN'<11*H*Q3&<?1Z:C.`B
M4>I%B@55^[!3H5%<BL/^X&]M/BXO&VK<D^V]B=&H73C9C2+K.3\(U)JJY<Y=
MQ53(\0_'\:W*!G<YF2JLB'7E%3=;NR,@.<>IXW3*X(F<^VE]PV3"+RE]O7G+
M=BI8:?.FU;XWYPM4ATDQ*^<K"2-Q7?I=V.Y<;R#I8$H>1<*=,"L8&ZI@CS$,
MR(M&GUC7TOK?4(>C\KS_`%7G)^F\C;J\_P`_J\KRNCQZM^G;QWT119]U;MWQ
MG/G`Z457U(Z'SCC%60L6(;)(F*BS=N7+9$LS19YX4AE$H&UI-DP!40$&CY)%
M?;I*<#2?VC[F.[=<E;=SZG;#>T9/'3X1_J-'@6Y^HKZ*'N[_`&R;W&XP^SMC
MIWVT.JV>?OX5+'G,AV0\`:>%50T-QIY!IYB<\?#88R,MFQI)*Q3C&;2L23JT
MD<)J>5ZHC5%$R*D*IX')(@?T!D1!0%>@=]6&,YCQ/]!;R6:^M_T)[=74UBK/
M(%F9)-&TS!.6"KJ?PCE0WUW&66-P=[:XMT!AH\BM2'9```GUHK)G;_[!^0:)
M/5'/_*W*4QBJ9J;MM9X+'F'K4>(MD,JQ_P"EBXN&4F2A$()%-$FSMK%"KU(]
M93NP`3%UJIW2_<3:;KMUQQGBVW-O+>5P;U9AKU>\`#&PTH:FH)\*X+:SM9^W
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MN([9K!:[-;DED0-2XN^]*<G'\(I[HKB5MGVD[/[=VUADNI'_`#.]RLHZ4B@:
M,RV('$#S=][V*7TO[(?9X?#41C`8FI\U-#/A%!3T7\SQBSD6Z[-^V0>LW2)V
M[IF[12<M'2"@"51%RV7(HBND<HB`E,40$-%])H]I[>7`:\2)YBY<)>)=IE5#
M'.K)3W';$<J^5.H.YU%G3RHK+JG./Q,8PB.B+WN,>(W%/";M*0PWQHP#BB11
M-UHR..</8]I<@D;;;=-]7:['NB"`!X;'#1$X,"`!3%W-\WQ$3?-\-O`?OVT1
M(HEQGXXHRB<XE@#":<VC(EF$IE/%-")*IRY'0/2RB<@2`*Z)(E>AYP+@8%05
M^<#=7CHB6X/#P^[1%YRTT^IWF&=UR[5BO7"NO_(%]7[3"QM@@WHM5R.FIG<3
M+-G;!R9LY2*HF)TQ$AR@8-A#?1%XBJX#P71)I*R4;#&**58FZ#AJA/U''=/K
M<VBV=E*1TW1EH:&9R"2#HA0*H0J@%.4-C`(:(E(EH:(GXM]"3T7'3<+)LUX^
M3B)=DVDHR28.DC(.F4@P>)+-'C1RB<2J)J$,0Y1$!`0T1)E6./F!*3.,;-3,
M(XAJ%CC//"-L%7QK2X";C_5-U6;GT4K%0C1^T]2T7.DIY:A>M,YBCN`B&B)7
M]$2/V?CW@.[33ZRW3".(;?8Y,$2R,_:,:TNP3;\K=`C5N5[*RT([?NP0;)%3
M)YBANDA0*&P``:(E3C8UA#L&45%,FL=&1S5NQCX]@V09L6#%HB1NT9,F;9-)
MLT:-6Z94TDDRE(F0H%*```!HB\S=,<X^R0P;Q61*-3K]%,WA9!G%W6L0EICF
MD@5)5`KYJRG6+]NW>`@L<GFD*!^@PAOL(AHB^FCXPQKC)O(-,;X]H^/VLLNB
MZE&U)J5?J;>2<MDC(MW$@C`1\>F\701,)2'4`QBE$0`0#1%^O9ZC5+O$.:_<
MZU7[=`/0`'D%9X:.GX9T!=]@<1DLV=LEM@$?VB#HB:/)]M/MUS3Y>2EN!_#N
M1D')^M=X\XV8=7<*G#?8YU3T\3"8!'X_?HB<#C/`F#<+-CL\.X9Q5BAJHF5)
M5OC;'M2HR2J1/$J:I*Q$1A52`/V&W#1$HLW"0UEB)&`L41&3T%,,UX^7A9I@
MTE8F48.B"DY8R,:_1<,WS-PF82G25(8ARCL("&B).*K@'!-%F6]CI&%L34RQ
M-$G+=K/U/'-.KDVV0>)&0=HMY6'AF;Y!)T@82*%(H`'(.QMPT1*WHB-$23VS
M`N#K]-+62]X:Q3=K"NW0:+3UNQW3[),J-6H&*U;*2DS#/'ZC=L4X@F0R@E(`
M[%``T1?GRG'#CU-I0R$U@G#<PA78LD'`(2F+Z-((P<(DNNZ2AH=-W!+$BXE)
MTY55*W0!-$%%#FZ>HPB)%[2EXXQ]C=BO%8[H]1H,2Y>'D7412JW"U6+=2"B"
M3920<Q\$R8-7#T[=!-,53E,?H(4N^P`&B+V1B@8-A_AX"`A^H0'1$@RO%3B^
MX.LJXXX8%<*N5%%7"JV'\>*J+JK&,HLJL<]<$55%3F$QC&W$PB(CHB6SZ7'?
M3?HWHFOTKT?T_P"G>G1]#Z#R?3^B]'Y?IO1^1_5^5T>7T?+MMX:(OM-MT_\`
M(_`?VNOI_9#X_P"K]_Z-=4F?W?@.?],O/Q75AICRI4>?GX?UI/T]OS-=?^7/
M_<QK_P`7U?F?_>:__6_M_!?_`#6_AZGJU[&T_3A3K4U^O2R\*^/V+QG_`++_
M`(V7^]_8D;YI_3?W9,K_`%G^Y/PI+?5_5?BO\(^A]`YZOS,_`?\`M!_*CSNC
M\2?0_P"T?I/G=/\`5>;KW<4K^NVO2_S>N-/3IU:_R>I^7U?P]3W*YK\WF.G]
M!N>KHZ73.KJ:NE3^?T_S.E^+I^]DOAPU\C]VG%WD?NS^1]";>3^Z?]0_(+RM
MB>7^!/J']H^EZ=NOU']=U[]?S;Z_3Y5J_P#13ZOU#7J-?G*?,?X]/N^RF%,E
MY>%Z?_.Q=/\`3=%!3Y/5\M3TU^]J_O>]DG7$^`_L_$?V=_Y]_MUB>%7?;7Z_
M3V++SX9KY!\`_P`FD5.F*4I3PR^M<'-=UV+A&B(T1&B(T1&B(T1&B(T1&B(T
C1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B+_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
